Log in to save to my catalogue

European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2779241365

European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

About this item

Full title

European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

Publisher

London: Normans Media Ltd

Journal title

M2 Pharma, 2023

Language

English

Publication information

Publisher

London: Normans Media Ltd

More information

Alternative Titles

Full title

European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2779241365

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2779241365

How to access this item